FDA Approved Products

Application #	Type	Sponsor	Product #	Drug Name	Form	Strength	Active Ingredient	Approval Date	Marketing Status	Reference Standard
761384	BLA	ABBVIE INC	001	EMRELIS	VIAL;SINGLE-DOSE	20MG	TELISOTUZUMAB VEDOTIN-TLLV	2025-05-14	Prescription	No
761384	BLA	ABBVIE INC	002	EMRELIS	VIAL;SINGLE-DOSE	100MG	TELISOTUZUMAB VEDOTIN-TLLV	2025-05-14	Prescription	No
217906	NDA	ABBVIE	001	EMBLAVEO	POWDER;INTRAVENOUS	EQ 0.5GM BASE/VIAL;1.5GM/VIAL	AVIBACTAM SODIUM; AZTREONAM	2025-02-07	Prescription	Yes
216962	NDA	ABBVIE	001	VYALEV	SOLUTION;SUBCUTANEOUS	120MG/10ML;2400MG/10ML (12MG/ML;240MG/ML)	FOSCARBIDOPA; FOSLEVODOPA	2024-10-16	Prescription	Yes
218347	NDA	ABBVIE	001	RINVOQ LQ	SOLUTION;ORAL	1MG/ML	UPADACITINIB	2024-04-26	Prescription	Yes
761262	BLA	ABBVIE INC	001	SKYRIZI	INJECTABLE;INTRAVENOUS	600MG/VIAL	RISANKIZUMAB-RZAA	2022-06-16	Prescription	No
214028	NDA	ABBVIE	001	VUITY	SOLUTION;OPHTHALMIC	1.25%	PILOCARPINE HYDROCHLORIDE	2021-10-28	Prescription	Yes
215206	NDA	ABBVIE	001	QULIPTA	TABLET;ORAL	10MG	ATOGEPANT	2021-09-28	Prescription	No
			002	QULIPTA	TABLET;ORAL	30MG	ATOGEPANT	2021-09-28	Prescription	No
			003	QULIPTA	TABLET;ORAL	60MG	ATOGEPANT	2021-09-28	Prescription	Yes
215110	NDA	ABBVIE	001	MAVYRET	PELLETS;ORAL	50MG;20MG/PACKET	GLECAPREVIR; PIBRENTASVIR	2021-06-10	Prescription	Yes
213388	NDA	ABBVIE	001	ORIAHNN (COPACKAGED)	CAPSULE;ORAL	EQ 300MG BASE,1MG,0.5MG; EQ 300MG BASE	ELAGOLIX SODIUM,ESTRADIOL,NORETHINDRONE ACETATE; ELAGOLIX SODIUM	2020-05-29	Prescription	Yes
211911	NDA	ABBVIE	001	DURYSTA	IMPLANT;OPHTHALMIC	10MCG	BIMATOPROST	2020-03-04	Prescription	Yes
211765	NDA	ABBVIE	001	UBRELVY	TABLET;ORAL	50MG	UBROGEPANT	2019-12-23	Prescription	No
211765	NDA	ABBVIE	002	UBRELVY	TABLET;ORAL	100MG	UBROGEPANT	2019-12-23	Prescription	Yes
211675	NDA	ABBVIE	001	RINVOQ	TABLET, EXTENDED RELEASE;ORAL	15MG	UPADACITINIB	2019-08-16	Prescription	No
			002	RINVOQ	TABLET, EXTENDED RELEASE;ORAL	30MG	UPADACITINIB	2019-08-16	Prescription	No
			003	RINVOQ	TABLET, EXTENDED RELEASE;ORAL	45MG	UPADACITINIB	2019-08-16	Prescription	Yes
761105	BLA	ABBVIE INC	001	SKYRIZI	INJECTABLE;INJECTION	75MG/0.83ML	RISANKIZUMAB-RZAA	2019-04-23	Prescription	No
761105	BLA	ABBVIE INC	002	SKYRIZI	INJECTABLE;INJECTION	150MG/ML	RISANKIZUMAB-RZAA	2019-04-23	Prescription	No
210450	NDA	ABBVIE	001	ORILISSA	TABLET;ORAL	EQ 150MG BASE	ELAGOLIX SODIUM	2018-07-23	Prescription	No
210450	NDA	ABBVIE	002	ORILISSA	TABLET;ORAL	EQ 200MG BASE	ELAGOLIX SODIUM	2018-07-23	Prescription	Yes
209394	NDA	ABBVIE	001	MAVYRET	TABLET;ORAL	100MG;40MG	GLECAPREVIR; PIBRENTASVIR	2017-08-03	Prescription	Yes
209512	NDA	ABBVIE	001	NORVIR	POWDER;ORAL	100MG/PACKET	RITONAVIR	2017-06-07	Prescription	Yes
208624	NDA	ABBVIE	001	VIEKIRA XR	TABLET, EXTENDED RELEASE;ORAL	EQ 200MG BASE;8.33MG;50MG;33.33MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	DASABUVIR SODIUM; OMBITASVIR; PARITAPREVIR; RITONAVIR	2016-07-22	Discontinued	No
206302	NDA	ABBVIE	001	BYVALSON	TABLET;ORAL	EQ 5MG BASE;80MG	NEBIVOLOL HYDROCHLORIDE; VALSARTAN	2016-06-03	Discontinued	No
208573	NDA	ABBVIE	001	VENCLEXTA	TABLET;ORAL	10MG	VENETOCLAX	2016-04-11	Prescription	No
			002	VENCLEXTA	TABLET;ORAL	50MG	VENETOCLAX	2016-04-11	Prescription	No
			003	VENCLEXTA	TABLET;ORAL	100MG	VENETOCLAX	2016-04-11	Prescription	Yes
204370	NDA	ABBVIE	001	VRAYLAR	CAPSULE;ORAL	EQ 1.5MG BASE	CARIPRAZINE HYDROCHLORIDE	2015-09-17	Prescription	Yes
			002	VRAYLAR	CAPSULE;ORAL	EQ 3MG BASE	CARIPRAZINE HYDROCHLORIDE	2015-09-17	Prescription	No
			003	VRAYLAR	CAPSULE;ORAL	EQ 4.5MG BASE	CARIPRAZINE HYDROCHLORIDE	2015-09-17	Prescription	No
			004	VRAYLAR	CAPSULE;ORAL	EQ 6MG BASE	CARIPRAZINE HYDROCHLORIDE	2015-09-17	Prescription	No
207931	NDA	ABBVIE	001	TECHNIVIE	TABLET;ORAL	12.5MG;75MG;50MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	OMBITASVIR; PARITAPREVIR; RITONAVIR	2015-07-24	Discontinued	No
206940	NDA	ABBVIE	001	VIBERZI	TABLET;ORAL	75MG	ELUXADOLINE	2015-05-27	Prescription	No
206940	NDA	ABBVIE	002	VIBERZI	TABLET;ORAL	100MG	ELUXADOLINE	2015-05-27	Prescription	Yes
206333	NDA	ABBVIE	001	KYBELLA	SOLUTION;SUBCUTANEOUS	20MG/2ML (10MG/ML)	DEOXYCHOLIC ACID	2015-04-29	Prescription	Yes
206494	NDA	ABBVIE	001	AVYCAZ	POWDER;INTRAVENOUS	EQ 0.5GM BASE;2GM/VIAL	AVIBACTAM SODIUM; CEFTAZIDIME	2015-02-25	Prescription	Yes
203952	NDA	ABBVIE	001	DUOPA	SUSPENSION;ENTERAL	4.63MG/ML;20MG/ML	CARBIDOPA; LEVODOPA	2015-01-09	Prescription	Yes
206439	NDA	ABBVIE	001	NAMZARIC	CAPSULE, EXTENDED RELEASE;ORAL	10MG;14MG	DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE	2014-12-23	Prescription	No
			002	NAMZARIC	CAPSULE, EXTENDED RELEASE;ORAL	10MG;28MG	DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE	2014-12-23	Prescription	Yes
			003	NAMZARIC	CAPSULE, EXTENDED RELEASE;ORAL	10MG;7MG	DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE	2014-12-23	Prescription	No
			004	NAMZARIC	CAPSULE, EXTENDED RELEASE;ORAL	10MG;21MG	DONEPEZIL HYDROCHLORIDE; MEMANTINE HYDROCHLORIDE	2014-12-23	Prescription	No
206619	NDA	ABBVIE	001	VIEKIRA PAK (COPACKAGED)	TABLET;ORAL	EQ 250MG BASE;12.5MG, 75MG, 50MG	DASABUVIR SODIUM; OMBITASVIR, PARITAPREVIR, RITONAVIR	2014-12-19	Discontinued	No
021883	NDA	ABBVIE	001	DALVANCE	POWDER;INTRAVENOUS	EQ 500MG BASE/VIAL	DALBAVANCIN HYDROCHLORIDE	2014-05-23	Prescription	Yes
204168	NDA	ABBVIE	001	FETZIMA	CAPSULE, EXTENDED RELEASE;ORAL	EQ 20MG BASE	LEVOMILNACIPRAN HYDROCHLORIDE	2013-07-25	Prescription	No
			002	FETZIMA	CAPSULE, EXTENDED RELEASE;ORAL	EQ 40MG BASE	LEVOMILNACIPRAN HYDROCHLORIDE	2013-07-25	Prescription	No
			003	FETZIMA	CAPSULE, EXTENDED RELEASE;ORAL	EQ 80MG BASE	LEVOMILNACIPRAN HYDROCHLORIDE	2013-07-25	Prescription	No
			004	FETZIMA	CAPSULE, EXTENDED RELEASE;ORAL	EQ 120MG BASE	LEVOMILNACIPRAN HYDROCHLORIDE	2013-07-25	Prescription	Yes
204412	NDA	ABBVIE	001	DELZICOL	CAPSULE, DELAYED RELEASE;ORAL	400MG	MESALAMINE	2013-02-01	Discontinued	No
202211	NDA	ABBVIE	001	OXYTROL FOR WOMEN	FILM, EXTENDED RELEASE;TRANSDERMAL	3.9MG/24HR	OXYBUTYNIN	2013-01-25	Over-the-counter	Yes
203696	NDA	ABBVIE ENDOCRINE	001	LUPANETA PACK	INJECTABLE, TABLET;INTRAMUSCULAR, ORAL	3.75MG/VIAL,N/A;N/A,5MG	LEUPROLIDE ACETATE; NORETHINDRONE ACETATE	2012-12-14	Discontinued	No
203696	NDA	ABBVIE ENDOCRINE	002	LUPANETA PACK	INJECTABLE, TABLET;INTRAMUSCULAR, ORAL	11.25MG/VIAL,N/A;N/A,5MG	LEUPROLIDE ACETATE; NORETHINDRONE ACETATE	2012-12-14	Discontinued	No
202811	NDA	ABBVIE	001	LINZESS	CAPSULE;ORAL	145MCG	LINACLOTIDE	2012-08-30	Prescription	Yes
			002	LINZESS	CAPSULE;ORAL	290MCG	LINACLOTIDE	2012-08-30	Prescription	No
			003	LINZESS	CAPSULE;ORAL	72MCG	LINACLOTIDE	2012-08-30	Prescription	Yes
021359	NDA	ABBVIE	001	RECTIV	OINTMENT;INTRA-ANAL	0.4%	NITROGLYCERIN	2011-06-21	Prescription	Yes
022567	NDA	ABBVIE	001	VIIBRYD	TABLET;ORAL	10MG	VILAZODONE HYDROCHLORIDE	2011-01-21	Prescription	Yes
			002	VIIBRYD	TABLET;ORAL	20MG	VILAZODONE HYDROCHLORIDE	2011-01-21	Prescription	No
			003	VIIBRYD	TABLET;ORAL	40MG	VILAZODONE HYDROCHLORIDE	2011-01-21	Prescription	No
200327	NDA	ABBVIE	001	TEFLARO	POWDER;INTRAVENOUS	400MG/VIAL	CEFTAROLINE FOSAMIL	2010-10-29	Prescription	Yes
200327	NDA	ABBVIE	002	TEFLARO	POWDER;INTRAVENOUS	600MG/VIAL	CEFTAROLINE FOSAMIL	2010-10-29	Prescription	Yes
022184	NDA	ABBVIE	001	LUMIGAN	SOLUTION/DROPS;OPHTHALMIC	0.01%	BIMATOPROST	2010-08-31	Prescription	Yes
022134	NDA	ABBVIE	001	LASTACAFT	SOLUTION/DROPS;OPHTHALMIC	0.25%	ALCAFTADINE	2010-07-28	Over-the-counter	Yes
022525	NDA	ABBVIE	001	NAMENDA XR	CAPSULE, EXTENDED RELEASE;ORAL	7MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	MEMANTINE HYDROCHLORIDE	2010-06-21	Discontinued	No
			002	NAMENDA XR	CAPSULE, EXTENDED RELEASE;ORAL	14MG	MEMANTINE HYDROCHLORIDE	2010-06-21	Discontinued	No
			003	NAMENDA XR	CAPSULE, EXTENDED RELEASE;ORAL	21MG	MEMANTINE HYDROCHLORIDE	2010-06-21	Discontinued	No
			004	NAMENDA XR	CAPSULE, EXTENDED RELEASE;ORAL	28MG	MEMANTINE HYDROCHLORIDE	2010-06-21	Discontinued	No
022548	NDA	ABBVIE	001	ZYMAXID	SOLUTION/DROPS;OPHTHALMIC	0.5%	GATIFLOXACIN	2010-05-18	Prescription	Yes
022417	NDA	ABBVIE	001	NORVIR	TABLET;ORAL	100MG	RITONAVIR	2010-02-10	Prescription	Yes
022427	NDA	ABBVIE	001	ACUVAIL	SOLUTION/DROPS;OPHTHALMIC	0.45%	KETOROLAC TROMETHAMINE	2009-07-22	Prescription	Yes
022315	NDA	ABBVIE	001	OZURDEX	IMPLANT;INTRAVITREAL	0.7MG	DEXAMETHASONE	2009-06-17	Prescription	Yes
020725	BLA	ABBVIE	001	CREON	CAPSULE, DELAYED RELEASE;ORAL	30,000USP UNITS;6,000USP UNITS;19,000USP UNITS	PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)	2009-04-30	Prescription	No
			002	CREON	CAPSULE, DELAYED RELEASE;ORAL	60,000USP UNITS;12,000USP UNITS;38,000USP UNITS	PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)	2009-04-30	Prescription	No
			003	CREON	CAPSULE, DELAYED RELEASE;ORAL	120,000USP UNITS;24,000USP UNITS;76,000USP UNITS	PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)	2009-04-30	Prescription	No
			004	CREON	CAPSULE, DELAYED RELEASE;ORAL	15,000USP UNITS;3,000USP UNITS;9,500USP UNITS	PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)	2009-04-30	Prescription	No
			005	CREON	CAPSULE, DELAYED RELEASE;ORAL	180,000USP UNITS;36,000USP UNITS;114,000USP UNITS	PANCRELIPASE (AMYLASE;LIPASE;PROTEASE)	2009-04-30	Prescription	No
022204	NDA	ABBVIE	001	GELNIQUE	GEL;TRANSDERMAL	10% (100MG/PACKET) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	OXYBUTYNIN CHLORIDE	2009-01-27	Discontinued	No
022256	NDA	ABBVIE	001	SAVELLA	TABLET;ORAL	12.5MG	MILNACIPRAN HYDROCHLORIDE	2009-01-14	Prescription	No
			002	SAVELLA	TABLET;ORAL	25MG	MILNACIPRAN HYDROCHLORIDE	2009-01-14	Prescription	No
			003	SAVELLA	TABLET;ORAL	50MG	MILNACIPRAN HYDROCHLORIDE	2009-01-14	Prescription	Yes
			004	SAVELLA	TABLET;ORAL	100MG	MILNACIPRAN HYDROCHLORIDE	2009-01-14	Prescription	No
022369	NDA	ABBVIE	001	LATISSE	SOLUTION/DROPS;TOPICAL	0.03%	BIMATOPROST	2008-12-24	Prescription	Yes
022224	NDA	ABBVIE	001	TRILIPIX	CAPSULE, DELAYED RELEASE;ORAL	EQ 45MG FENOFIBRIC ACID	CHOLINE FENOFIBRATE	2008-12-15	Discontinued	No
022224	NDA	ABBVIE	002	TRILIPIX	CAPSULE, DELAYED RELEASE;ORAL	EQ 135MG FENOFIBRIC ACID	CHOLINE FENOFIBRATE	2008-12-15	Discontinued	No
022206	NDA	ABBVIE	001	RAPAFLO	CAPSULE;ORAL	4MG	SILODOSIN	2008-10-08	Discontinued	No
022206	NDA	ABBVIE	002	RAPAFLO	CAPSULE;ORAL	8MG	SILODOSIN	2008-10-08	Discontinued	No
021830	NDA	ABBVIE	001	ASACOL HD	TABLET, DELAYED RELEASE;ORAL	800MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	MESALAMINE	2008-05-29	Discontinued	No
022267	NDA	ABBVIE INC	001	DEPAKOTE ER	TABLET, EXTENDED RELEASE; ORAL	250MG	DIVALPROEX SODIUM	2008-03-24	Prescription	No
022267	NDA	ABBVIE INC	002	DEPAKOTE ER	TABLET, EXTENDED RELEASE; ORAL	500MG	DIVALPROEX SODIUM	2008-03-24	Prescription	No
021398	NDA	ABBVIE	001	COMBIGAN	SOLUTION/DROPS;OPHTHALMIC	0.2%;EQ 0.5% BASE	BRIMONIDINE TARTRATE; TIMOLOL MALEATE	2007-10-30	Prescription	Yes
021906	NDA	ABBVIE	001	KALETRA	TABLET;ORAL	200MG;50MG	LOPINAVIR; RITONAVIR	2005-10-28	Prescription	Yes
021906	NDA	ABBVIE	002	KALETRA	TABLET;ORAL	100MG;25MG	LOPINAVIR; RITONAVIR	2005-10-28	Prescription	No
021770	NDA	ABBVIE	001	ALPHAGAN P	SOLUTION/DROPS;OPHTHALMIC	0.1%	BRIMONIDINE TARTRATE	2005-08-19	Prescription	Yes
021794	NDA	ABBVIE	001	ACZONE	GEL;TOPICAL	5%	DAPSONE	2005-07-07	Prescription	Yes
021606	NDA	ABBVIE	001	ZEMPLAR	CAPSULE;ORAL	1MCG	PARICALCITOL	2005-05-26	Prescription	No
			002	ZEMPLAR	CAPSULE;ORAL	2MCG	PARICALCITOL	2005-05-26	Prescription	No
			003	ZEMPLAR	CAPSULE;ORAL	4MCG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	PARICALCITOL	2005-05-26	Discontinued	No
021513	NDA	ABBVIE	001	ENABLEX	TABLET, EXTENDED RELEASE;ORAL	EQ 7.5MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	DARIFENACIN HYDROBROMIDE	2004-12-22	Discontinued	No
021513	NDA	ABBVIE	002	ENABLEX	TABLET, EXTENDED RELEASE;ORAL	EQ 15MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	DARIFENACIN HYDROBROMIDE	2004-12-22	Discontinued	No
021656	NDA	ABBVIE	001	TRICOR	TABLET;ORAL	48MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	FENOFIBRATE	2004-11-05	Discontinued	No
021656	NDA	ABBVIE	002	TRICOR	TABLET;ORAL	145MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	FENOFIBRATE	2004-11-05	Discontinued	No
021487	NDA	ABBVIE	001	NAMENDA	TABLET;ORAL	5MG	MEMANTINE HYDROCHLORIDE	2003-10-16	Prescription	No
021487	NDA	ABBVIE	002	NAMENDA	TABLET;ORAL	10MG	MEMANTINE HYDROCHLORIDE	2003-10-16	Prescription	Yes
021528	NDA	ABBVIE	001	ACULAR LS	SOLUTION/DROPS;OPHTHALMIC	0.4%	KETOROLAC TROMETHAMINE	2003-05-30	Prescription	Yes
125057	BLA	ABBVIE INC	001	HUMIRA	SYRINGE	40MG/0.8ML	ADALIMUMAB	2002-12-31	Prescription	No
125057	BLA	ABBVIE INC	002	HUMIRA	VIAL	40MG/0.8ML	ADALIMUMAB	2002-12-31	Prescription	No
050790	NDA	ABBVIE	001	RESTASIS	EMULSION;OPHTHALMIC	0.05%	CYCLOSPORINE	2002-12-23	Prescription	Yes
050790	NDA	ABBVIE	002	RESTASIS MULTIDOSE	EMULSION;OPHTHALMIC	0.05%	CYCLOSPORINE	2002-12-23	Prescription	Yes
021365	NDA	ABBVIE	001	LEXAPRO	SOLUTION;ORAL	EQ 5MG BASE/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	ESCITALOPRAM OXALATE	2002-11-27	Discontinued	No
021323	NDA	ABBVIE	001	LEXAPRO	TABLET;ORAL	EQ 5MG BASE	ESCITALOPRAM OXALATE	2002-08-14	Prescription	No
			002	LEXAPRO	TABLET;ORAL	EQ 10MG BASE	ESCITALOPRAM OXALATE	2002-08-14	Prescription	No
			003	LEXAPRO	TABLET;ORAL	EQ 20MG BASE	ESCITALOPRAM OXALATE	2002-08-14	Prescription	Yes
021402	NDA	ABBVIE	001	SYNTHROID	TABLET;ORAL	0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	LEVOTHYROXINE SODIUM	2002-07-24	Prescription	No
			002	SYNTHROID	TABLET;ORAL	0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	LEVOTHYROXINE SODIUM	2002-07-24	Prescription	No
			003	SYNTHROID	TABLET;ORAL	0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	LEVOTHYROXINE SODIUM	2002-07-24	Prescription	No
			004	SYNTHROID	TABLET;ORAL	0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	LEVOTHYROXINE SODIUM	2002-07-24	Prescription	No
			005	SYNTHROID	TABLET;ORAL	0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	LEVOTHYROXINE SODIUM	2002-07-24	Prescription	No
			006	SYNTHROID	TABLET;ORAL	0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	LEVOTHYROXINE SODIUM	2002-07-24	Prescription	No
			007	SYNTHROID	TABLET;ORAL	0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	LEVOTHYROXINE SODIUM	2002-07-24	Prescription	No
			008	SYNTHROID	TABLET;ORAL	0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	LEVOTHYROXINE SODIUM	2002-07-24	Prescription	No
			009	SYNTHROID	TABLET;ORAL	0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	LEVOTHYROXINE SODIUM	2002-07-24	Prescription	No
			010	SYNTHROID	TABLET;ORAL	0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	LEVOTHYROXINE SODIUM	2002-07-24	Prescription	No
			011	SYNTHROID	TABLET;ORAL	0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	LEVOTHYROXINE SODIUM	2002-07-24	Prescription	Yes
			012	SYNTHROID	TABLET;ORAL	0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium	LEVOTHYROXINE SODIUM	2002-07-24	Prescription	No
075729	ANDA	ABBVIE	001	FAMOTIDINE PRESERVATIVE FREE IN PLASTIC CONTAINER	INJECTABLE;INJECTION	0.4MG/ML	FAMOTIDINE	2001-12-17	Discontinued	No
021268	NDA	ABBVIE	001	TEVETEN HCT	TABLET;ORAL	600MG;12.5MG	EPROSARTAN MESYLATE; HYDROCHLOROTHIAZIDE	2001-11-01	Discontinued	No
021268	NDA	ABBVIE	002	TEVETEN HCT	TABLET;ORAL	600MG;25MG	EPROSARTAN MESYLATE; HYDROCHLOROTHIAZIDE	2001-11-01	Discontinued	No
021203	NDA	ABBVIE	001	TRICOR	TABLET;ORAL	54MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	FENOFIBRATE	2001-09-04	Discontinued	No
021203	NDA	ABBVIE	003	TRICOR	TABLET;ORAL	160MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	FENOFIBRATE	2001-09-04	Discontinued	No
021262	NDA	ABBVIE	001	ALPHAGAN P	SOLUTION/DROPS;OPHTHALMIC	0.15%	BRIMONIDINE TARTRATE	2001-03-16	Prescription	Yes
021275	NDA	ABBVIE	001	LUMIGAN	SOLUTION/DROPS;OPHTHALMIC	0.03% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	BIMATOPROST	2001-03-16	Discontinued	No
021252	NDA	ABBVIE	001	CANASA	SUPPOSITORY;RECTAL	500MG	MESALAMINE	2001-01-05	Discontinued	No
021252	NDA	ABBVIE	002	CANASA	SUPPOSITORY;RECTAL	1GM	MESALAMINE	2001-01-05	Prescription	Yes
021226	NDA	ABBVIE	001	KALETRA	CAPSULE;ORAL	133.3MG;33.3MG	LOPINAVIR; RITONAVIR	2000-09-15	Discontinued	No
021251	NDA	ABBVIE	001	KALETRA	SOLUTION;ORAL	80MG/ML;20MG/ML	LOPINAVIR; RITONAVIR	2000-09-15	Prescription	Yes
021168	NDA	ABBVIE	001	DEPAKOTE ER	TABLET, EXTENDED RELEASE;ORAL	EQ 500MG VALPROIC ACID	DIVALPROEX SODIUM	2000-08-04	Prescription	No
021168	NDA	ABBVIE	002	DEPAKOTE ER	TABLET, EXTENDED RELEASE;ORAL	EQ 250MG VALPROIC ACID	DIVALPROEX SODIUM	2000-08-04	Prescription	No
021145	NDA	ABBVIE	001	VANIQA	CREAM;TOPICAL	13.9%	EFLORNITHINE HYDROCHLORIDE	2000-07-27	Discontinued	No
065003	ANDA	ABBVIE	001	GENGRAF	CAPSULE;ORAL	25MG	CYCLOSPORINE	2000-05-12	Prescription	No
			002	GENGRAF	CAPSULE;ORAL	50MG	CYCLOSPORINE	2000-05-12	Discontinued	No
			003	GENGRAF	CAPSULE;ORAL	100MG	CYCLOSPORINE	2000-05-12	Prescription	No
050775	NDA	ABBVIE	001	BIAXIN XL	TABLET, EXTENDED RELEASE;ORAL	500MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CLARITHROMYCIN	2000-03-03	Discontinued	No
065025	ANDA	ABBVIE	001	CYCLOSPORINE	SOLUTION;ORAL	100MG/ML	CYCLOSPORINE	2000-03-03	Discontinued	No
075114	ANDA	ABBVIE	001	ACYCLOVIR	INJECTABLE;INJECTION	EQ 50MG BASE/ML	ACYCLOVIR SODIUM	1999-07-26	Discontinued	No
020945	NDA	ABBVIE	001	NORVIR	CAPSULE;ORAL	100MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	RITONAVIR	1999-06-29	Discontinued	No
020822	NDA	ABBVIE	001	CELEXA	TABLET;ORAL	EQ 10MG BASE	CITALOPRAM HYDROBROMIDE	1998-07-17	Prescription	No
			002	CELEXA	TABLET;ORAL	EQ 20MG BASE	CITALOPRAM HYDROBROMIDE	1998-07-17	Prescription	No
			003	CELEXA	TABLET;ORAL	EQ 40MG BASE	CITALOPRAM HYDROBROMIDE	1998-07-17	Prescription	Yes
			004	CELEXA	TABLET;ORAL	EQ 60MG BASE	CITALOPRAM HYDROBROMIDE	1998-07-17	Discontinued	No
020819	NDA	ABBVIE	001	ZEMPLAR	SOLUTION;INTRAVENOUS	0.005MG/ML (0.005MG/ML)	PARICALCITOL	1998-04-17	Prescription	Yes
			002	ZEMPLAR	SOLUTION;INTRAVENOUS	0.002MG/ML (0.002MG/ML)	PARICALCITOL	1998-04-17	Prescription	Yes
			003	ZEMPLAR	SOLUTION;INTRAVENOUS	0.01MG/2ML (0.005MG/ML)	PARICALCITOL	1998-04-17	Prescription	Yes
020738	NDA	ABBVIE	004	TEVETEN	TABLET;ORAL	EQ 300MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	EPROSARTAN MESYLATE	1997-12-22	Discontinued	No
			005	TEVETEN	TABLET;ORAL	EQ 400MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	EPROSARTAN MESYLATE	1997-12-22	Discontinued	No
			006	TEVETEN	TABLET;ORAL	EQ 600MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	EPROSARTAN MESYLATE	1997-12-22	Discontinued	No
020675	NDA	ABBVIE	001	URSO 250	TABLET;ORAL	250MG	URSODIOL	1997-12-10	Discontinued	No
020675	NDA	ABBVIE	002	URSO FORTE	TABLET;ORAL	500MG	URSODIOL	1997-12-10	Discontinued	No
050739	NDA	ABBVIE	001	OMNICEF	CAPSULE;ORAL	300MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CEFDINIR	1997-12-04	Discontinued	No
050749	NDA	ABBVIE	001	OMNICEF	FOR SUSPENSION;ORAL	125MG/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CEFDINIR	1997-12-04	Discontinued	No
050749	NDA	ABBVIE	002	OMNICEF	FOR SUSPENSION;ORAL	250MG/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CEFDINIR	1997-12-04	Discontinued	No
020716	NDA	ABBVIE	001	VICOPROFEN	TABLET;ORAL	7.5MG;200MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	HYDROCODONE BITARTRATE; IBUPROFEN	1997-09-23	Discontinued	No
020701	NDA	ABBVIE	001	CRINONE	GEL;VAGINAL	4%	PROGESTERONE	1997-07-31	Prescription	Yes
020701	NDA	ABBVIE	002	CRINONE	GEL;VAGINAL	8%	PROGESTERONE	1997-07-31	Prescription	Yes
020381	NDA	ABBVIE	001	NIASPAN	TABLET, EXTENDED RELEASE;ORAL	375MG	NIACIN	1997-07-28	Discontinued	No
			002	NIASPAN	TABLET, EXTENDED RELEASE;ORAL	500MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	NIACIN	1997-07-28	Discontinued	No
			003	NIASPAN	TABLET, EXTENDED RELEASE;ORAL	750MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	NIACIN	1997-07-28	Discontinued	No
			004	NIASPAN	TABLET, EXTENDED RELEASE;ORAL	1GM Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	NIACIN	1997-07-28	Discontinued	No
			005	NIASPAN TITRATION STARTER PACK	TABLET, EXTENDED RELEASE;ORAL	375MG;500MG;750MG	NIACIN	1997-07-28	Discontinued	No
020600	NDA	ABBVIE	001	TAZORAC	GEL;TOPICAL	0.05%	TAZAROTENE	1997-06-13	Prescription	Yes
020600	NDA	ABBVIE	002	TAZORAC	GEL;TOPICAL	0.1%	TAZAROTENE	1997-06-13	Prescription	Yes
074638	ANDA	ABBVIE	001	IOPAMIDOL-300	INJECTABLE;INJECTION	61%	IOPAMIDOL	1997-04-30	Discontinued	No
020708	NDA	ABBVIE ENDOCRINE INC	001	LUPRON DEPOT	INJECTABLE;INJECTION	11.25MG	LEUPROLIDE ACETATE	1997-03-07	Prescription	Yes
020593	NDA	ABBVIE	001	DEPACON	INJECTABLE;INJECTION	EQ 100MG BASE/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	VALPROATE SODIUM	1996-12-30	Discontinued	No
020655	NDA	ABBVIE	001	ALORA	FILM, EXTENDED RELEASE;TRANSDERMAL	0.05MG/24HR	ESTRADIOL	1996-12-20	Discontinued	No
			002	ALORA	FILM, EXTENDED RELEASE;TRANSDERMAL	0.075MG/24HR	ESTRADIOL	1996-12-20	Discontinued	No
			003	ALORA	FILM, EXTENDED RELEASE;TRANSDERMAL	0.1MG/24HR	ESTRADIOL	1996-12-20	Discontinued	No
			004	ALORA	FILM, EXTENDED RELEASE;TRANSDERMAL	0.025MG/24HR	ESTRADIOL	1996-12-20	Discontinued	No
020591	NDA	ABBVIE	001	TARKA	TABLET, EXTENDED RELEASE;ORAL	2MG;180MG	TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE	1996-10-22	Discontinued	No
			002	TARKA	TABLET, EXTENDED RELEASE;ORAL	4MG;240MG	TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE	1996-10-22	Discontinued	No
			003	TARKA	TABLET, EXTENDED RELEASE;ORAL	1MG;240MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE	1996-10-22	Discontinued	No
			004	TARKA	TABLET, EXTENDED RELEASE;ORAL	2MG;240MG	TRANDOLAPRIL; VERAPAMIL HYDROCHLORIDE	1996-10-22	Discontinued	No
040117	ANDA	ABBVIE	001	VICODIN HP	TABLET;ORAL	660MG;10MG	ACETAMINOPHEN; HYDROCODONE BITARTRATE	1996-09-23	Discontinued	No
020528	NDA	ABBVIE	001	MAVIK	TABLET;ORAL	1MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TRANDOLAPRIL	1996-04-26	Discontinued	No
			002	MAVIK	TABLET;ORAL	2MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TRANDOLAPRIL	1996-04-26	Discontinued	No
			003	MAVIK	TABLET;ORAL	4MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TRANDOLAPRIL	1996-04-26	Discontinued	No
020659	NDA	ABBVIE	001	NORVIR	SOLUTION;ORAL	80MG/ML	RITONAVIR	1996-03-01	Discontinued	No
020517	NDA	ABBVIE ENDOCRINE INC	001	LUPRON DEPOT	INJECTABLE;INJECTION	22.5MG	LEUPROLIDE ACETATE	1995-12-22	Prescription	No
			002	LUPRON DEPOT	INJECTABLE;INJECTION	30MG	LEUPROLIDE ACETATE	1995-12-22	Prescription	Yes
			003	LUPRON DEPOT	INJECTABLE;INJECTION	45MG	LEUPROLIDE ACETATE	1995-12-22	Prescription	Yes
020551	NDA	ABBVIE	001	NIMBEX	INJECTABLE;INJECTION	EQ 2MG BASE/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CISATRACURIUM BESYLATE	1995-12-15	Discontinued	No
			002	NIMBEX PRESERVATIVE FREE	INJECTABLE;INJECTION	EQ 10MG BASE/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CISATRACURIUM BESYLATE	1995-12-15	Discontinued	No
			003	NIMBEX PRESERVATIVE FREE	INJECTABLE;INJECTION	EQ 2MG BASE/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CISATRACURIUM BESYLATE	1995-12-15	Discontinued	No
020489	NDA	ABBVIE	001	ANDRODERM	FILM, EXTENDED RELEASE;TRANSDERMAL	2.5MG/24HR	TESTOSTERONE	1995-09-29	Discontinued	No
			002	ANDRODERM	FILM, EXTENDED RELEASE;TRANSDERMAL	5MG/24HR	TESTOSTERONE	1995-09-29	Discontinued	No
			003	ANDRODERM	FILM, EXTENDED RELEASE;TRANSDERMAL	2MG/24HR Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TESTOSTERONE	1995-09-29	Discontinued	No
			004	ANDRODERM	FILM, EXTENDED RELEASE;TRANSDERMAL	4MG/24HR Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	TESTOSTERONE	1995-09-29	Discontinued	No
020478	NDA	ABBVIE	001	ULTANE	LIQUID;INHALATION	100%	SEVOFLURANE	1995-06-07	Prescription	Yes
019943	NDA	ABBVIE ENDOCRINE INC	002	LUPRON DEPOT	INJECTABLE; INJECTION	3.75MG	LEUPROLIDE ACETATE	1995-03-30	Prescription	No
019304	NDA	ABBVIE	001	LIPIDIL	CAPSULE;ORAL	100MG	FENOFIBRATE	1993-12-31	Discontinued	No
			002	TRICOR (MICRONIZED)	CAPSULE;ORAL	67MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	FENOFIBRATE	1993-12-31	Discontinued	No
			003	TRICOR (MICRONIZED)	CAPSULE;ORAL	134MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	FENOFIBRATE	1993-12-31	Discontinued	No
			004	TRICOR (MICRONIZED)	CAPSULE;ORAL	200MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	FENOFIBRATE	1993-12-31	Discontinued	No
050698	NDA	ABBVIE	001	BIAXIN	FOR SUSPENSION;ORAL	125MG/5ML	CLARITHROMYCIN	1993-12-23	Discontinued	No
			002	BIAXIN	FOR SUSPENSION;ORAL	250MG/5ML	CLARITHROMYCIN	1993-12-23	Discontinued	No
			003	BIAXIN	FOR SUSPENSION;ORAL	187MG/5ML	CLARITHROMYCIN	1993-12-23	Discontinued	No
050697	NDA	ABBVIE INC	001	BIAXIN XL	TABLET;ORAL	250MG	CLARITHROMYCIN	1993-12-23	Prescription	No
050697	NDA	ABBVIE INC	002	BIAXIN XL	TABLET;ORAL	500MG	CLARITHROMYCIN	1993-12-23	Prescription	No
019183	NDA	ABBVIE	001	CARAFATE	SUSPENSION;ORAL	1GM/10ML	SUCRALFATE	1993-12-16	Prescription	Yes
020263	NDA	ABBVIE ENDOCRINE INC	002	LUPRON DEPOT-PED KIT	POWDER;INTRAMUSCULAR	7.5MG	LEUPROLIDE ACETATE	1993-04-16	Prescription	Yes
			003	LUPRON DEPOT-PED KIT	POWDER;INTRAMUSCULAR	3.75MG,7.5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	LEUPROLIDE ACETATE	1993-04-16	Discontinued	No
			004	LUPRON DEPOT-PED KIT	POWDER;INTRAMUSCULAR	7.5MG,7.5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	LEUPROLIDE ACETATE	1993-04-16	Discontinued	No
			005	LUPRON DEPOT-PED KIT	POWDER;INTRAMUSCULAR	11.25MG	LEUPROLIDE ACETATE	1993-04-16	Prescription	Yes
			006	LUPRON DEPOT-PED KIT	POWDER;INTRAMUSCULAR	15MG	LEUPROLIDE ACETATE	1993-04-16	Prescription	Yes
			007	LUPRON DEPOT-PED KIT	POWDER;INTRAMUSCULAR	11.25MG	LEUPROLIDE ACETATE	1993-04-16	Prescription	Yes
			008	LUPRON DEPOT-PED KIT	POWDER;INTRAMUSCULAR	30MG	LEUPROLIDE ACETATE	1993-04-16	Prescription	Yes
			009	LUPRON DEPOT-PED KIT	POWDER;INTRAMUSCULAR	45MG	LEUPROLIDE ACETATE	1993-04-16	Prescription	Yes
020200	NDA	ABBVIE	001	NALBUPHINE HYDROCHLORIDE	INJECTABLE;INJECTION	1.5MG/ML	NALBUPHINE HYDROCHLORIDE	1993-03-12	Discontinued	No
019700	NDA	ABBVIE	001	ACULAR	SOLUTION/DROPS;OPHTHALMIC	0.5%	KETOROLAC TROMETHAMINE	1992-11-09	Prescription	Yes
020098	NDA	ABBVIE	001	MIVACRON	SOLUTION;INTRAVENOUS	EQ 2MG BASE/ML (EQ 2MG BASE/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	MIVACURIUM CHLORIDE	1992-01-22	Discontinued	No
			004	MIVACRON	SOLUTION;INTRAVENOUS	EQ 10MG BASE/5ML (EQ 2MG BASE/ML)	MIVACURIUM CHLORIDE	1992-01-22	Discontinued	No
			005	MIVACRON	SOLUTION;INTRAVENOUS	EQ 20MG BASE/10ML (EQ 2MG BASE/ML)	MIVACURIUM CHLORIDE	1992-01-22	Discontinued	No
			002	MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINER	INJECTABLE;INJECTION	EQ 0.5MG BASE/ML	MIVACURIUM CHLORIDE	1992-01-22	Discontinued	No
			003	MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINER	INJECTABLE;INJECTION	EQ 50MG BASE/100ML	MIVACURIUM CHLORIDE	1992-01-22	Discontinued	No
050662	NDA	ABBVIE	001	BIAXIN	TABLET;ORAL	250MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CLARITHROMYCIN	1991-10-31	Discontinued	No
050662	NDA	ABBVIE	002	BIAXIN	TABLET;ORAL	500MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CLARITHROMYCIN	1991-10-31	Discontinued	No
020032	BLA	ABBVIE	001	SURVANTA	SUSPENSION;INTRATRACHEAL	25MG/ML	BERACTANT	1991-07-01	Prescription	No
019946	NDA	ABBVIE	001	NUROMAX	INJECTABLE;INJECTION	EQ 1MG BASE/ML	DOXACURIUM CHLORIDE	1991-03-07	Discontinued	No
020011	NDA	ABBVIE ENDOCRINE INC	001	LUPRON DEPOT	INJECTABLE;INJECTION	3.75MG/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	LEUPROLIDE ACETATE	1990-10-22	Discontinued	No
020011	NDA	ABBVIE ENDOCRINE INC	002	LUPRON DEPOT	INJECTABLE;INJECTION	3.75MG	LEUPROLIDE ACETATE	1990-10-22	Prescription	Yes
019680	NDA	ABBVIE	001	DEPAKOTE	CAPSULE, DELAYED REL PELLETS;ORAL	EQ 125MG VALPROIC ACID	DIVALPROEX SODIUM	1989-09-12	Prescription	Yes
019732	NDA	ABBVIE ENDOCRINE INC	001	LUPRON DEPOT	INJECTABLE;INJECTION	7.5MG	LEUPROLIDE ACETATE	1989-01-26	Prescription	Yes
019204	NDA	ABBVIE	001	CARTROL	TABLET;ORAL	2.5MG	CARTEOLOL HYDROCHLORIDE	1988-12-28	Discontinued	No
			002	CARTROL	TABLET;ORAL	5MG	CARTEOLOL HYDROCHLORIDE	1988-12-28	Discontinued	No
			003	CARTROL	TABLET;ORAL	10MG	CARTEOLOL HYDROCHLORIDE	1988-12-28	Discontinued	No
089736	ANDA	ABBVIE	001	VICODIN ES	TABLET;ORAL	750MG;7.5MG	ACETAMINOPHEN; HYDROCODONE BITARTRATE	1988-12-09	Discontinued	No
071295	ANDA	ABBVIE	001	ATROPINE	SOLUTION;INTRAMUSCULAR	EQ 2MG SULFATE/0.7ML	ATROPINE	1987-01-30	Discontinued	No
018874	NDA	ABBVIE	001	CALCIJEX	INJECTABLE;INJECTION	0.001MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CALCITRIOL	1986-09-25	Discontinued	No
018874	NDA	ABBVIE	002	CALCIJEX	INJECTABLE;INJECTION	0.002MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	CALCITRIOL	1986-09-25	Discontinued	No
019216	NDA	ABBVIE	001	FML FORTE	SUSPENSION/DROPS;OPHTHALMIC	0.25%	FLUOROMETHOLONE	1986-04-23	Prescription	Yes
019010	NDA	ABBVIE ENDOCRINE INC	001	LUPRON	SOLUTION;SUBCUTANEOUS	14MG/2.8ML (1MG/0.2ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	LEUPROLIDE ACETATE	1985-04-09	Discontinued	No
018723	NDA	ABBVIE	001	DEPAKOTE	TABLET, DELAYED RELEASE;ORAL	EQ 250MG VALPROIC ACID	DIVALPROEX SODIUM	1983-03-10	Prescription	No
			002	DEPAKOTE	TABLET, DELAYED RELEASE;ORAL	EQ 500MG VALPROIC ACID	DIVALPROEX SODIUM	1983-03-10	Prescription	Yes
			003	DEPAKOTE	TABLET, DELAYED RELEASE;ORAL	EQ 125MG VALPROIC ACID	DIVALPROEX SODIUM	1983-03-10	Prescription	No
088058	ANDA	ABBVIE	001	VICODIN	TABLET;ORAL	500MG;5MG	ACETAMINOPHEN; HYDROCODONE BITARTRATE	1983-01-07	Discontinued	No
018117	NDA	ABBVIE	001	AZMACORT	AEROSOL, METERED;INHALATION	0.1MG/INH	TRIAMCINOLONE ACETONIDE	1982-04-23	Discontinued	No
018333	NDA	ABBVIE	001	CARAFATE	TABLET;ORAL	1GM	SUCRALFATE	1981-10-30	Prescription	Yes
018450	NDA	ABBVIE	001	NITROPRESS	INJECTABLE;INJECTION	50MG/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	SODIUM NITROPRUSSIDE	1981-09-08	Discontinued	No
018279	NDA	ABBVIE	001	K-TAB	TABLET, EXTENDED RELEASE;ORAL	10MEQ Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	POTASSIUM CHLORIDE	1980-06-09	Discontinued	No
			002	K-TAB	TABLET, EXTENDED RELEASE;ORAL	8MEQ Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	POTASSIUM CHLORIDE	1980-06-09	Discontinued	No
			003	K-TAB	TABLET, EXTENDED RELEASE;ORAL	20MEQ Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	POTASSIUM CHLORIDE	1980-06-09	Discontinued	No
018081	NDA	ABBVIE	001	DEPAKENE	CAPSULE;ORAL	250MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	VALPROIC ACID	1978-02-28	Discontinued	No
018082	NDA	ABBVIE	001	DEPAKENE	SYRUP;ORAL	250MG/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	VALPROIC ACID	1978-02-28	Discontinued	No
017011	NDA	ABBVIE	001	PRED FORTE	SUSPENSION/DROPS;OPHTHALMIC	1%	PREDNISOLONE ACETATE	1973-05-30	Prescription	Yes
017100	NDA	ABBVIE	001	PRED MILD	SUSPENSION/DROPS;OPHTHALMIC	0.12%	PREDNISOLONE ACETATE	1972-11-10	Prescription	Yes
016851	NDA	ABBVIE	002	FML	SUSPENSION/DROPS;OPHTHALMIC	0.1%	FLUOROMETHOLONE	1972-01-12	Prescription	Yes
005932	NDA	ABBVIE	012	AMINOSOL 5%	INJECTABLE;INJECTION	5%	PROTEIN HYDROLYSATE		Discontinued	No
087847	ANDA	ABBVIE	001	ATROPINE AND DEMEROL	INJECTABLE;INJECTION	0.4MG/ML;75MG/ML	ATROPINE SULFATE; MEPERIDINE HYDROCHLORIDE		Discontinued	No
087848	ANDA	ABBVIE	001	ATROPINE AND DEMEROL	INJECTABLE;INJECTION	0.4MG/ML;100MG/ML	ATROPINE SULFATE; MEPERIDINE HYDROCHLORIDE		Discontinued	No
087853	ANDA	ABBVIE	001	ATROPINE AND DEMEROL	INJECTABLE;INJECTION	0.4MG/ML;50MG/ML	ATROPINE SULFATE; MEPERIDINE HYDROCHLORIDE		Discontinued	No
006044	NDA	ABBVIE	003	DIASONE SODIUM	TABLET, DELAYED RELEASE;ORAL	165MG	SULFOXONE SODIUM		Discontinued	No
008322	NDA	ABBVIE	001	GEMONIL	TABLET;ORAL	100MG	METHARBITAL		Discontinued	No
006905	NDA	ABBVIE	002	NORISODRINE	POWDER;INHALATION	25%	ISOPROTERENOL SULFATE		Discontinued	No
006905	NDA	ABBVIE	003	NORISODRINE	POWDER;INHALATION	10%	ISOPROTERENOL SULFATE		Discontinued	No
004125	NDA	ABBVIE	005	SULFADIAZINE	TABLET;ORAL	300MG	SULFADIAZINE		Discontinued	No
012302	NDA	ABBVIE	002	CHOLOXIN	TABLET;ORAL	2MG	DEXTROTHYROXINE SODIUM	1967-04-14	Discontinued	No
			004	CHOLOXIN	TABLET;ORAL	4MG	DEXTROTHYROXINE SODIUM	1967-04-14	Discontinued	No
			005	CHOLOXIN	TABLET;ORAL	1MG	DEXTROTHYROXINE SODIUM	1967-04-14	Discontinued	No
			006	CHOLOXIN	TABLET;ORAL	6MG	DEXTROTHYROXINE SODIUM	1967-04-14	Discontinued	No
010021	NDA	ABBVIE	002	PLACIDYL	CAPSULE;ORAL	500MG	ETHCHLORVYNOL	1961-05-10	Discontinued	No
			004	PLACIDYL	CAPSULE;ORAL	100MG	ETHCHLORVYNOL	1961-05-10	Discontinued	No
			007	PLACIDYL	CAPSULE;ORAL	200MG	ETHCHLORVYNOL	1961-05-10	Discontinued	No
			010	PLACIDYL	CAPSULE;ORAL	750MG	ETHCHLORVYNOL	1961-05-10	Discontinued	No
012418	NDA	ABBVIE	002	AKINETON	INJECTABLE;INJECTION	5MG/ML	BIPERIDEN LACTATE	1961-04-20	Discontinued	No
012524	NDA	ABBVIE	001	ENDURON	TABLET;ORAL	2.5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	METHYCLOTHIAZIDE	1960-10-21	Discontinued	No
012524	NDA	ABBVIE	004	ENDURON	TABLET;ORAL	5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	METHYCLOTHIAZIDE	1960-10-21	Discontinued	No
012148	NDA	ABBVIE	001	ORETICYL 25	TABLET;ORAL	0.125MG;25MG	DESERPIDINE; HYDROCHLOROTHIAZIDE	1959-12-14	Discontinued	No
			003	ORETICYL 50	TABLET;ORAL	0.125MG;50MG	DESERPIDINE; HYDROCHLOROTHIAZIDE	1959-12-14	Discontinued	No
			002	ORETICYL FORTE	TABLET;ORAL	0.25MG;25MG	DESERPIDINE; HYDROCHLOROTHIAZIDE	1959-12-14	Discontinued	No
012003	NDA	ABBVIE	001	AKINETON	TABLET;ORAL	2MG	BIPERIDEN HYDROCHLORIDE	1959-09-08	Discontinued	No
011971	NDA	ABBVIE	001	ORETIC	TABLET;ORAL	25MG	HYDROCHLOROTHIAZIDE	1959-07-06	Discontinued	No
011971	NDA	ABBVIE	002	ORETIC	TABLET;ORAL	50MG	HYDROCHLOROTHIAZIDE	1959-07-06	Discontinued	No
010796	NDA	ABBVIE	001	HARMONYL	TABLET;ORAL	0.1MG	DESERPIDINE	1957-04-19	Discontinued	No
010796	NDA	ABBVIE	002	HARMONYL	TABLET;ORAL	0.25MG	DESERPIDINE	1957-04-19	Discontinued	No
010599	NDA	ABBVIE	001	TRAL	TABLET;ORAL	25MG	HEXOCYCLIUM METHYLSULFATE	1957-02-13	Discontinued	No
008370	NDA	ABBVIE	001	BENTYL	INJECTABLE;INJECTION	10MG/ML	DICYCLOMINE HYDROCHLORIDE	1952-08-13	Discontinued	No
008370	NDA	ABBVIE	002	BENTYL PRESERVATIVE FREE	INJECTABLE;INJECTION	10MG/ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	DICYCLOMINE HYDROCHLORIDE	1952-08-13	Discontinued	No
007707	NDA	ABBVIE	001	PHENURONE	TABLET;ORAL	500MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons	PHENACEMIDE	1951-06-28	Discontinued	No
006800	NDA	ABBVIE	001	PARADIONE	CAPSULE;ORAL	300MG	PARAMETHADIONE	1949-06-15	Discontinued	No
			002	PARADIONE	SOLUTION;ORAL	300MG/ML	PARAMETHADIONE	1949-06-15	Discontinued	No
			003	PARADIONE	CAPSULE;ORAL	150MG	PARAMETHADIONE	1949-06-15	Discontinued	No
005856	NDA	ABBVIE	002	TRIDIONE	SOLUTION;ORAL	200MG/5ML	TRIMETHADIONE	1946-01-25	Discontinued	No
			005	TRIDIONE	CAPSULE;ORAL	300MG	TRIMETHADIONE	1946-01-25	Discontinued	No
			009	TRIDIONE	TABLET;ORAL	150MG	TRIMETHADIONE	1946-01-25	Discontinued	No
005545	NDA	ABBVIE	003	DICUMAROL	TABLET;ORAL	25MG	DICUMAROL	1944-07-31	Discontinued	No
			004	DICUMAROL	TABLET;ORAL	50MG	DICUMAROL	1944-07-31	Discontinued	No
			005	DICUMAROL	TABLET;ORAL	100MG	DICUMAROL	1944-07-31	Discontinued	No